OptiNose (NASDAQ: OPTN) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $19.8 million versus the consensus estimate of $18.68 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.